The body recognizes these virus-like proteins as foreign invaders and can then mount an immune response against the actual virus. The burst of announcements followed the publication last week of results of Moderna Inc’s () vaccine trial, showing similarly promising early results. Several manufacturers have U.S. government backing with a goal of having a coronavirus vaccine by year’s end as cases continue to rise at a record pace. Recent studies show that some recovered patients who tested negative for coronavirus antibodies developed T cells in response to their infection. Scientists think both are important aspects of an effective coronavirus vaccine.

Source: Standard Digital July 21, 2020 07:31 UTC